GLP-1 Market
LLY $1362.68 ▼ -0.2% NVO $40.34 ▲ +0.1% PFE $29.34 ▼ -1.8% VKTX $26.95 ▲ +4.5% KLRA $13.16 ▲ +8.1% GPCR $20.98 ▲ +9.9% RHHBY $59.38 ▼ -2.6%
Market data delayed up to 20 min · Source: Twelve Data
GLP-1 & Obesity Medicine

Find My Trial

Search obesity and metabolic clinical trials by health condition, treatment type, and location.

Not sure where to start? Choose a health condition, select oral or injectable, or search for a drug you're curious about.

About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Health conditions
Select conditions
Match
Route
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

More filters
Reset